Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach (2020)
Source: Pharmaceuticals. Unidade: FFCLRP
Subjects: ANTI-INFLAMATÓRIOS, BIOINFORMÁTICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Rozires P. et al. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach. Pharmaceuticals, v. 13, n. 9, p. 1-26, 2020Tradução . . Disponível em: https://doi.org/10.3390/ph13090209. Acesso em: 19 out. 2024.APA
Leão, R. P., Cruz, J. V., Costa, G. V. da, Cruz, J. N., Ferreira, E. F. B., Silva, R. C., et al. (2020). Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach. Pharmaceuticals, 13( 9), 1-26. doi:10.3390/ph13090209NLM
Leão RP, Cruz JV, Costa GV da, Cruz JN, Ferreira EFB, Silva RC, Lima LR de, Borges RS, Santos GB dos, Santos CBR. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach [Internet]. Pharmaceuticals. 2020 ; 13( 9): 1-26.[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/ph13090209Vancouver
Leão RP, Cruz JV, Costa GV da, Cruz JN, Ferreira EFB, Silva RC, Lima LR de, Borges RS, Santos GB dos, Santos CBR. Identification of new rofecoxib-based cyclooxygenase-2 inhibitors: a bioinformatics approach [Internet]. Pharmaceuticals. 2020 ; 13( 9): 1-26.[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/ph13090209